Current Therapeutic Research

Editorial comment
pp. 529-529(1)
Author: Connor J.D.

Unconventional treatments for inflammatory bowel disease
pp. 530-536(7)
Author: Guslandi M.

Effects of troglitazone on coagulation-fibrinolysis abnormalities in patients with type II diabetes mellitus
pp. 537-544(8)
Author: Kubo K.

Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients
pp. 545-555(11)
Authors: Descamps O.; Hondekijn J.-C.; Godrie T.; Desager J.-P.; Heller F.R.

Expression of intestinal drug-metabolizing enzymes in patients with chronic inflammatory bowel disease
pp. 556-563(8)
Authors: Klotz U.; Hoensch H.; Schutz T.; Beaune P.; Zanger U.; Bode J.C.; Fritz P.

Trials in special populations - Editorial comment
pp. 565-566(2)
Author: Connor J.D.

Prophylactic treatment with loratadine versus cromolyn sodium in children with mild-to-moderate perennial allergic asthma
pp. 567-578(12)
Authors: Menardo J.-L.; Wessel F.; Cougnard J.; Czarlewski W.

Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: a randomized trial
pp. 579-588(10)
Authors: Diez-Domingo J.; Planelles M.V.; Baldo J.M.; Ballester A.; Nunez F.; Jubert A.; Dominguez-Granados R.

Effects of alendronate sodium on severe osteodystrophy in postmenopausal patients with primary biliary cirrhosis: a pilot study
pp. 589-593(5)
Authors: Floreani A.; Tizian L.; Luisetto G.; Buda A.; Mega A.; Naccarato R.